Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Hepatocellular 2Solid Tumor 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Glioblastoma 1Carcinosarcoma 1Camurati-Engelmann Syndrome 1

Interventions

Paclitaxel 5Carboplatin 3Taxes 2Specimen Handling 2Nivolumab 2Biopsy 2rucaparib 1rebastinib 1pembrolizumab 1olaparib 1durvalumab 1cediranib 1capivasertib 1cabozantinib 1Magnetic Resonance Spectroscopy 1LY-2157299 1Immunoglobulin G 1Ifosfamide 1Fluid Therapy 1Disulfides 1DCC-2036 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinosarcoma × LY-2157299 × Clear all
NCT03206177 2024-08-07

Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary

University of Oklahoma

Phase 1 Completed
26 enrolled 13 charts
Sarcoma

Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡